Manuel Sierra Montesinos

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

J.M. Fernández Gómez, Rosário Madero, Eduardo Solsona et al. · The Journal of Urology · 2009 · 655 citations · Full text

Medicine, Oncology, Urology +9

Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

J.M. Fernández Gómez, Eduardo Solsona, Miguel Unda et al. · European Urology · 2007 · 257 citations · Full text

Medicine, Oncology, Urology +6

The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables

J.M. Fernández Gómez, Rosário Madero, Eduardo Solsona et al. · European Urology · 2011 · 166 citations · Full text

Medicine, Oncology, Urology +8

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

Luis Martínez‐Piñeiro, José Antonio Portillo, José A. Zabala et al. · European Urology · 2015 · 80 citations · Full text

Medicine, Oncology, Urology +6

Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial

Eduardo Solsona, Rosário Madero, V. Chantada et al. · European Urology · 2014 · 73 citations · Full text

Medicine, Oncology, Urology +10